HOME     SUBSCRIBERS     TRADE     PRODUCTS & SERVICES    
About Sharenet
Enter any share name or code:    

16-Nov-2018
(Official Notice)
Shareholders are advised that Afro-C has noted an error in the Form of Proxy for use in connection with the General Meeting convened to be held on 10 January 2019 in terms of the Circular to shareholders dated and posted to shareholders on 9 November 2018, relative to the Activo Health (Pty) Ltd. acquisition ("Circular").



Proxy Form correction

In paragraph two on the face of the Form of Proxy the date of the General Meeting is incorrectly reflected as being 5 December 2018 and not 10 January 2019 as is stated on the Notice of General Meeting and throughout the Circular. Shareholders should note that the date of the General Meeting is 10 January 2019 and not as incorrectly stated on the face of the Form of Proxy.



The Form of Proxy remains valid, with the correction above.
09-Nov-2018
(Official Notice)
AfroCentric shareholders ("Shareholders") are referred to the announcement published on the Stock Exchange News Service ("SENS") on 9 October 2018 wherein they were advised that AfroCentric had, via its subsidiary, ACT Healthcare Assets Proprietary Limited, concluded an agreement in terms of which it will acquire 74% in Activo Health Proprietary Limited, from WAD Holdings Limited and Messrs SE Claassen and JPF Martin, for an aggregate purchase consideration of R588 million, which will be settled by means of a combination of cash and the issue of AfroCentric ordinary shares ("Transaction").



A circular ("Circular") has been posted to Shareholders today, 9 November 2018, containing, inter alia:

*details of the Transaction; and

*a notice convening a general meeting of Shareholders ("General Meeting").



The Circular is also available for viewing on the Company?s website at http://www.afrocentric.za.com/inv-circulars.php Shareholders are advised to review the Circular for a summary of the material terms and conditions of the Transaction.



Notice of GM

The General Meeting will be held at Medscheme Head Office, 37 Conrad Street, Florida North, Roodepoort on Thursday, 10 January 2019 at 10:00 to consider and, if deemed fit, pass, with or without modification, the resolutions necessary to implement the Transaction.



Important dates and times

The salient dates and times relating to the General Meeting are set out in the timetable below ("Timetable"). Words and expressions in the Timetable and notes thereto shall have the same meaning as assigned to them in the Circular.



Event: 2018

*Record Date for Shareholders to be recorded in the Register in order to receive this Circular on Friday, 2 November

*Circular containing the Notice convening the General Meeting posted to Shareholders onFriday, 9 November

*Last Day to Trade in Shares in order to be recorded in the Register to vote at the General Meeting onMonday, 31 December



Event: 2019

*Record Date for Shareholders to be recorded in the Register in order to be eligible to vote at the General Meeting on Friday, 4 January

*Forms of proxy for the General Meeting to be received by the Transfer Secretaries by 10:00 on Tuesday, 8 January

*General Meeting held at 10:00 on Thursday, 10 January

*Results of the General Meeting published on SENS on Thursday, 10 January
08-Nov-2018
(Official Notice)
Shareholders are advised that at the annual general meeting held on Wednesday, 8 November 2018 ("AGM"), all resolutions as set out in the notice of the AGM which was incorporated in the 2018 Integrated Annual Report and distributed to shareholders on 9 October 2018, were duly approved by the requisite majority of shareholders present and voting, either in person or represented by proxy.



Changes to the board

In compliance with paragraph 3.59 of the JSE Limited Listings Requirements, the Afro-C board of directors notified shareholders that the Founding Directors, Meyer Kahn and Motty Sacks, have decided to retire from the Board, with effect from 8 November 2018.
09-Oct-2018
(Official Notice)
Shareholders of Afro-C (?Shareholders?) are advised that the Notice of Annual General Meeting, Form of Proxy and Summarised Audited Consolidated Financial Statements (?2018 Summarised AFS?) have been posted to Shareholders and made available on the website; www.Afro-C.za.com/cd-ar-reports.php today, 9 October 2018.



A full set of audited annual financial statements of the Company for the year ended 30 June 2018 (?2018 AFS?) as well as the 2018 integrated report (?Integrated Report?) will be also be available on the Company?s website today, 9 October 2018. Should you wish to receive a printed copy of the 2018 AFS and the Integrated Report, please forward an email request to: investor-relations@Afro-C.za.com



The 2018 Summarised AFS, 2018 AFS and Integrated Report contain no modifications to the summary of audited final results and dividend declaration published on SENS on 14 September 2018.



Notice was given that the 12th annual general meeting of Shareholders for the year ended 30 June 2018 will be held at the Afro-C Distribution Services Offices, the Greens Office Park, Building L, 26 Charles De Gaulle Crescent, Highveld Ext 12, Centurion on Thursday, 8 November 2018 at 10h00 to transact the business as set out in the Notice of the Annual General Meeting.
09-Oct-2018
(Official Notice)
17-Sep-2018
(Official Notice)
The board of Afro-C notified shareholders that Mr Vijay Pillay has resigned as Group Chief Technology Director and Executive Director of Medscheme Holdings (Pty) Ltd., a major subsidiary of the Company, with effect from 30 September 2018.
14-Sep-2018
(C)
24-Aug-2018
(Official Notice)
AfroCentric shareholders were advised that:

- basic earnings per share (EPS) for the current reporting period is expected to be between 43.31 cents and 46.71 cents reflecting an increase of between 104.00% and 120.02% when compared to the 21.23 cents reported in the previous corresponding period; and

- headline earnings per share (HEPS) for the current reporting period is expected to be between 43.96 cents and 47.54 cents reflecting an increase of between 96.78% and 112.80% when compared to the 22.34 cents reported in the previous corresponding period.



Shareholder attention is drawn to the two IFRS provisions in the June 2017 Income Statement, one relating to the Sanlam share subscription profit warranty and the second pertaining to the suspensive Tranche 2 payment for the WAD acquisition. Both of these corporate matters were successfully concluded during the reporting period, making IFRS provisions in each case no longer relevant or applicable. Absent the aforesaid provisions, EPS and HEPS now reveals a realistic measurement of the performance of the AfroCentric Group.



The financial results are scheduled to be published on or about 17 September 2018.
20-Jul-2018
(Official Notice)
Shareholders and investors will have read an article published on a news website on 16 July 2018, wherein it was pondered as to whether Afro-C had adequately disclosed the contingent extent of an unresolved damages claim launched by NHA against a subsidiary of the Company in 2007.



While the Group?s legal advisors have consistently advised the Board that the NHA claim has no merit, the Afro-C Board has annually disclosed all details of the claim (subject to a confidential arbitration process) to its auditors each year since it was instituted in 2007 and that the Group?s 2017 Annual Financial Statements records as a provision, the maximum loss relating to a component of the claim, in the unlikely event of the claim being awarded in favour of NHA.



A hearing on the merits of the claim has yet to take place. Afro-C remains confident that it enjoys strong prospects of successfully defending the claim and obtaining an award for costs against NHA.



The full extent of the claim by NHA was also noted and disclosed as a contingent liability in the 2017 Annual Financial statements, but the probability of the claim materialising after 11 years still appears to be remote. Since the NHA claim was initiated, material transactions have taken place with vendors to and investors in Afro-C, each conducting comprehensive due diligence exercises, which included consideration of the contingent claim by NHA.



Finally it is important to note that in 2008, the shareholders of NHA sold NHA to a company in the Liberty Group and have not denied that NHA is today merely an empty corporate shell. The Afro-C subsidiary has lodged an application for leave to appeal the judgement refusing security.
01-Jun-2018
(Official Notice)
19-Mar-2018
(C)
Healthcare services revenue grew to R1.4 billion (2016: R1.3 billion). Total healthcare operating profit increased by 9.62% to R283.6 million (2016: R258.8 million). Comprehensive net income for the period attributable to equity holders of the parent increased to R115.9 million (2016: R98.0 million). Furthermore, headline earnings per share came to 21.67 cents per share (2016: 18.21 cents per share).



Dividends

The board announces that an interim dividend of 16 cents per ordinary share (gross) has been declared for the six months ended 31 December 2017. Dividends are subject to Dividends Withholding Tax.



Company prospects

AfroCentric has once again delivered a solid operating result, particularly during an interim period laced with challenging politics and economic uncertainty. It was a period characterised by a lack of economic growth and declining consumer disposable incomes. Notwithstanding the above, the benefits of the Group?s maintained programme of expansion, including the general and sustained quality of earnings from within the underlying businesses, all contributed to the more than satisfactory financial outcome of the Group during this period under review.



The Group?s financial position remains sound, cash generation is strong and it retains adequate headroom to accommodate expansion opportunities. At corporate and operational level, management is assessing and implementing plans for real growth and pursuing selective local and international opportunities to complement the existing product and service offering.



23-Feb-2018
(Official Notice)
AfroCentric shareholders are advised that ;

*diluted earnings per share for the six month period ended 31 December 2017 (?current reporting period?) is expected to be between 21.18 cents and 22.05 cents, reflecting an increase of between 21.68% and 26.68% in comparison to the 17.41 cents per share reported in the previous corresponding period

*diluted headline earnings per share for the current reporting period is expected to be between 21.24 cents and 22.10 cents reflecting an increase of between 22.11% and 27.11% in comparison to the 17.39 cents per share reported in the previous corresponding period.

*basic earnings per share for the current reporting period is expected to be between 21.17 cents and 22.08 cents reflecting an increase of between 16.10% to and 21.10% in comparison to the 18.23 cents per share reported in the previous corresponding period; and

*headline earnings per share for the current reporting period is expected to be between 21.21 cents and 22.13 cents reflecting an increase of between 16.50% to 21.50% in comparison to the 18.21 cents per share reported in the previous corresponding period.



The financial results on which this trading statement is based have not been reviewed or reported on by AfroCentric?s external auditors.



The interim financial results are scheduled to be published on or about 20 March 2018.

19-Jan-2018
(Official Notice)
The Board of Directors of Afro-C (?the Board?) notified shareholders that Mr Kevin Michael Aron has resigned as an Executive Director and Chief Executive Officer of Medscheme Holdings (Pty) Ltd. with immediate effect.



Mr Anthony Bruce Severin Pedersen, currently the Managing Director of Helios IT Solutions, has been appointed as the new Chief Executive Officer of Medscheme Holdings (Pty) Ltd. with immediate effect. Mr Pederson is a Chartered Accountant and was previously General Manager of Momentum Health in Mauritius, where he was responsible for establishing the new insurance business.
12-Dec-2017
(Official Notice)
Shareholders are advised that the annual compliance report and certificate in terms of Section 13G(2) of the B-BBEE Amendment Act No. 46 of 2013, is available on the Company?s website www.afrocentric.za.com.

08-Nov-2017
(Official Notice)
Shareholders are advised that at the annual general meeting held on Wednesday, 8 November 2017 (?AGM?), all resolutions as set out in the notice of the AGM which was incorporated in the 2017 Integrated Annual Report and distributed to shareholders on 10 October 2017, were duly approved by the requisite majority of shareholders present and voting, either in person or represented by proxy.



Shareholders are advised that:

*the total number of shares in issue as at the date of the AGM was 554 377 328;

*the total number of shares that were present in person/represented by proxy at the AGM was 426 099 606 shares being 77% of the total number of shares in issue; and

*Abstentions are represented below as a percentage of total number of shares in issue.

10-Oct-2017
(Official Notice)
Shareholders of AfroCentric (?Shareholders?) are advised that the audited annual financial statements of the Company for the year ended 30 June 2017 (?2017 AFS?) as well as the 2017 integrated report (?Integrated Report?), were posted to Shareholders today, 10 October 2017. The 2017 AFS and Integrated Report contain no modifications to the summary of audited final results and dividend declaration published on SENS on 19 September 2017.



Notice was given that the 11th annual general meeting of Shareholders for the year ended 30 June 2017 will be held at the AfroCentric Distribution Services Offices, the Greens Office Park, Building L, 26 Charles De Gaulle Crescent, Highveld Ext 12, Centurion on Wednesday, 8 November 2017 at 10h00 to transact the business as set out in the notice of the annual general meeting, which forms a part of the Integrated Report.
28-Sep-2017
(Official Notice)
AfroCentric shareholders (?Shareholders?) are referred to the SENS announcement dated 30 September 2014 (and using the terms defined therein unless otherwise stated) wherein AfroCentric announced the commercial terms for the WAD Acquisitions.



The consideration for the WAD Acquisitions was to be settled in separate tranches, in the first instance, being an aggregate initial fair value consideration of R465.6 million, which was settled through the issue of 86.5 million AfroCentric ordinary shares (?AfroCentric Shares?) and R20 million in cash. The effective date of the transaction was 1 August 2015.



Measurement of and payment method for second tranche payment

The commercial terms of the WAD Acquisitions included, inter alia, a reward formula for certain performance metrics to be measured on 30 June 2017, including certain profit warranties and contractual relationships being in place beyond 30 June 2018.



Given the measurement of performance for the two year period to 30 June 2017 and in terms of the second tranche formula, a further 31 366 977 million AfroCentric Shares are due to be issued to WAD by 30 September 2017. Shareholders will note that this contingency was reflected and appropriately provided for in the 2016 Audited Annual Financial Statements and the 2017 Audited year end results announced on 19 September 2017. WAD requested that in lieu of the issue of the 31 366 977 AfroCentric Shares, that they receive this second tranche payment in cash. The Board considered the reciprocal implications and the non-dilutionary advantage to shareholders and approved an attributable payment of an amount of R194 475 257.40 in consideration thereof. It should also be noted that WAD maintains its current shareholding of 16.03% in the Group.



The fulfilment of certain further suspensive conditions applicable for review on 30 June 2018 in terms of the WAD Acquisitions, may on fulfilment, trigger a maximum further payment of R80.6 million subject to fair value adjustments, payable to WAD in AfroCentric Shares or cash as determined at the relevant time.



Categorisation of the WAD Acquisitions

Shareholders are reminded that the WAD Acquisitions were regarded as a Category 2 transaction in terms of the JSE Limited Listings Requirements and accordingly the acquisition did not require shareholder approval.
19-Sep-2017
(C)
19-Sep-2017
(Official Notice)
Shareholders are referred to the ?Revised Trading Statement and Restatement of Financial Information? announcement released on SENS on 27 March 2017 wherein shareholders were advised of the restatement to the financial results for the year ended 30 June 2016 due to the incorrect accounting treatment of the interest accrued on the Sanlam Put Option Obligation which was recognised through the Conditional Put Option Reserve and Obligation rather than the Statement of Comprehensive Income.



Further to the above, shareholders are hereby advised of additional restatements to previously published financial information as detailed below.



Restatement 1: Classification of the cash flows



In the prior financial year, loans to Group companies were incorrectly disclosed as a separate line under investing activities instead of financing activities. Due to its materiality a decision was taken to restate the prior year statement of cash flows.



Restatement 2: Earnings per share and headline earnings per share

In the prior years, AfroCentric calculated the earnings per share (?EPS?) and headline earnings per share (?HEPS?) using the total comprehensive income attributable to the parent instead of profit and loss attributable to the parent and added back impairment of loans for HEPS purposes. From management?s analysis the change in the EPS and HEPS is immaterial. The restated results from 2013, 2014 and 2015 have also been provided from a completeness perspective. The need for this restatement was identified during the audit for the financial year ended 30 June 2017.



The financial results for the year ended 30 June 2017 are expected to be published on SENS on Tuesday, 19 September 2017.

17-Aug-2017
(Official Notice)
The board of directors of Afro-C notified shareholders that Mr Gawie Erasmus has resigned as an executive director and chief executive officer of Pharmacy Direct (Pty) Ltd. with effect from 31 August 2017.
16-May-2017
(Official Notice)
The AfroCentric board of directors notified shareholders that Ms Hlokammoni Grathel Motau has been appointed as an independent non-executive director of the company and a member of the Audit and Risk Committee with effect from 15 May 2017.
21-Apr-2017
(Official Notice)
Afro-C board of directors (?the Board?) notified shareholders that Ms Shireen Lutchan has resigned as Company Secretary with immediate effect.



As an interim measure the Board has appointed Billy Mokale (B Proc, LLB, DIP Co LAW, PMD) as the Company Secretary. Billy is currently the General Manager heading up the Legal, Risk, Governance and Compliance functions for the AfroCentric Group. A permanent appointment will be made within the period stipulated by the Companies Act.
28-Mar-2017
(C)
Healthcare service revenue grew to R1.3 billion (R1.1 billion). Total healthcare operating profit jumped to R258.8 million (R208.6 million). Profit attributable to equity holders lowered to R98.0 million (R99.2 million). Furthermore, headline earnings per share decreased to 17.22 cents per share (18.10 cents per share).



Dividends

The board announced that an interim dividend of 14 cents per ordinary share (gross) has been declared for the six months ended 31 December 2016.



Company prospects

While the economic environment within South Africa remains somewhat volatile and uncertain, AfroCentric remains confident in pursuing its interest in welcoming and facilitating the current market inclination towards medical administration consolidation. The Group also continues its objectives to acquire new and expand existing healthcare enterprises, so as to broaden its participation in the healthcare sector, ideally under a template of a widening market and better patient affordability.



AfroCentric has over the years, established a secure foundation for the future and its partnerships with Sanlam and others, present a sound model for sustainability, somewhat dependent on the progress and growth of the South African economy, including its political stability, with similar criteria being relevant and applicable in other targeted destinations in Africa.
27-Mar-2017
(Official Notice)
15-Mar-2017
(Official Notice)
The AfroCentric board of directors notified shareholders that Ms NV Qangule has resigned as an independent non-executive director and as a member of the Audit and Risk Committee with immediate effect.
14-Feb-2017
(Official Notice)
AfroCentric shareholders are advised of the following:

- earnings per share for the six months ended 31 December 2016 is expected to be between 21.38 cents and 22.28 cents, reflecting an increase of between 18.91% and 23.91% in comparison to 17.98 cents reported in the prior comparative period; and

- headline earnings per share for the six months ended 31 December 2016 is expected to be between 20.91 cents and 21.81 cents, reflecting an increase of between 15.51% and 20.51% in comparison to 18.10 cents reported in the prior comparative period.



The interim results are expected to be published on SENS on or about 17 March 2017.
29-Nov-2016
(Official Notice)
The AfroCentric board of directors (?the board?) hereby notifies shareholders of the following changes to the board with effect from 30 November 2016:

- Ms NV Qangule is appointed as an independent non-executive director and as a Member of the Audit and Risk Committee.

- Mr SE Mmakau is appointed as an independent non-executive director and as a member of the Audit and Risk Committee.

- Mr JM Kahn, an existing independent non-executive director and senior member on the Board, will take up the role of the Lead independent non-executive director.
04-Nov-2016
(Official Notice)
Shareholders are referred to the "Changes to the Board and Results of the Annual General Meeting" announcement released on SENS on Wednesday, 2 November 2016 (?the Announcement?) and are advised that the voting results relating to ordinary resolution number 2.1 for the re-election of Mr JG Appelgryn as a director and ordinary resolution number 3.3 for the re-appointment of Mr A Banderker as a member of the audit committee were incorrectly collated at the annual general meeting.



Given the result of ordinary resolution number 2.1, Mr JG Appelgryn has ceased to serve as a non-executive director of the company with effect from 1 November 2016.
02-Nov-2016
(Official Notice)
Shareholders are advised that:

- Mr Garth Napier has resigned as an independent non-executive director, member of the Audit and Risk Committee and member of the Social and Ethics Committee with effect from 1 November 2016; and

- Dr Brigalia Bam has resigned as an independent non-executive director and member of the Social and Ethics Committee with effect from 1 November 2016.



The board is in the process of appointing new members and shareholders will be updated as soon as new board members are appointed.



Results of the annual general meeting

Shareholders are advised that at the annual general meeting held on Tuesday, 1 November 2016 (?AGM?), all resolutions as set out in the notice of the AGM which was incorporated in the 2016 Integrated Annual Report and distributed to shareholders on 3 October 2016, with the exception of ordinary resolution numbers 2.1, 2.2, 2.3 and 3.2, (see notes 1 and 2 below), were duly approved by the requisite majority of shareholders.
03-Oct-2016
(Official Notice)
Shareholders of AfroCentric (?Shareholders?) are hereby advised that the audited annual financial statements of the Company for the year ended 30 June 2016, as contained in the 2016 integrated annual report (?Integrated Report?), were posted to Shareholders on 3 October 2016, and contain no modifications to the audited results which were published on SENS on 19 September 2016.



Notice of the Annual General Meeting (?AGM?)

Notice is hereby given that the AGM of the Company will be held on Tuesday, 1 November 2016 at 10:00 at The AfroCentric Distribution Services Offices, the Greens Office Park, Building L, 26 Charles De Gaulle Crescent, Highveld Ext 12, Centurion to transact the business as set out in the notice of the AGM, which forms a part of the Integrated Report.
19-Sep-2016
(C)
15-Sep-2016
(Official Notice)
The company advises shareholders that Ms Yasmin Masithela has tendered her resignation as an Independent Non-Executive Director with effect from today, 15 September 2016.

03-Jun-2016
(Official Notice)
The company advised shareholders that Mr Dewald Dempers tendered his resignation as an Executive Director on 02 June 2016.
17-Mar-2016
(C)
Sales and service revenue grew 41.91% to R1.4 billion (R1.0 billion). Operating profit was 19.42% higher at R208.6 million (R174.7 million). Total comprehensive income for the period attributable to equity holders jumped to R99.2 million (R94.8 million). In addition, headline earnings per share decreased to 18.1 cents per share (21.84 cents per share).



Interim dividend

Given the strong cash position and performance of the Group, the board of directors has pleasure in announcing that the company?s interim dividend of 12 cents per ordinary share (gross) has been declared for the six months ended 31 December 2015. Dividends are subject to Dividends Withholding Tax. The payment date for the dividend is Monday, 16 May 2016. This interim dividend will constitute part of the Group?s annual dividend, to be considered with the results for the 30 June 2016 year-end.



Prospects

Given all of the events and corporate actions that have occurred during the period under review, the Group has positively positioned itself for future growth and further development. It has taken some years to reach this point of Group sustainability and absent some unforeseen circumstances, it is expected that the Group will continue to make progress in all of its enterprises. The relationship with SANLAM holds some exciting prospects for expansion, not only in South Africa but in destinations on the continent of Africa, where SANLAM already has a presence. Notwithstanding the above, stakeholders will be acutely aware of the economic challenges which lie ahead. Recent increases in interest rates, consequential inflation and the volatile Rand exchange rates have all had an effect on the South African economy and will likely impact disposable income and business confidence. The company's talented management team will nevertheless continue to diligently manage the Group?s expanded and growing operating portfolio, at the same time seeking to optimise the returns and opportunities that present themselves for review and consideration.
16-Mar-2016
(Official Notice)
Shareholders of AfroCentric (?Shareholders?) are referred to the announcement published on SENS on 8 December 2015 wherein the company advised that Mr Dewald Dempers had stepped down as CEO of the company, and that the role would temporarily be filled by the Non-Executive Chairman, Dr Anna Mokgokong while the company finalised the appointment of a new CEO.



Shareholders are now advised that, in compliance with the JSE Ltd. Listings Requirements, the board of AfroCentric (?the board?) is pleased to announce that Mr Antoine Vorster van Buuren has been appointed as CEO of the company with effect from 16 March 2016.



Antoine joins the company as CEO after serving as CEO to the AfroCentric Health Group Ltd., a wholly owned subsidiary of AfroCentric since 1 August 2015. Antoine entered the healthcare sector in 2004 when he jointly founded WAD Holdings. He previously served as CEO of WAD subsidiary companies Pharmacy Direct, a courier pharmacy business, and Curasana Wholesalers, a pharmaceutical wholesaler. Prior to founding WAD Holdings, he spent 15 years with Total both in South Africa and internationally, including holding general management positions responsible for logistics and retail. Antoine holds a B.Comm in Accounting from the University of Pretoria and an MBA from the University Of Pretoria Graduate School Of Business.
05-Feb-2016
(Official Notice)
The board of directors of AfroCentric hereby advises that at the Annual General Meeting of shareholders held on Friday, 5 February 2016 (?AGM?), the following resolutions, as set out in the notice of Annual General Meeting which was incorporated in the Integrated Annual Report distributed to shareholders on 18 December 2015 were duly approved by the requisite majority of shareholders present (in person or represented by proxy) and voting:



Shareholders are advised of the following:

*total number of shares in issue as at the date of the AGM: 554 377 328;

*total number of shares that were present in person/represented including proxies at the AGM: 398 202 613 shares being 72% of the total number of shares in issue; and

*Abstentions are represented below as a percentage of total number of shares in issue.



31-Dec-2015
(Official Notice)
Shareholders of AfroCentric (?Shareholders?) are hereby advised that the audited annual financial statements of the Company for the year ended 30 June 2015, as contained in the integrated annual report 2015 (?Integrated Report?), were posted to Shareholders on 18 December 2015, and contain no modifications to the audited results which were published on SENS on 22 September 2015.



Notice of the Annual General Meeting (?AGM?)

Notice is hereby given that the AGM of the Company will be held on Friday, 5 February 2016 at 10:00 at The Bonitas Marketing Company Offices, the Greens Office Park, Building L, 26 Charles De Gaulle Crescent, Highveld Ext 12, Centurion to transact the business as set out in the notice of the AGM, which forms a part of the Integrated Report.



Record date

The record date on which shareholders must be recorded as such in the Company?s securities register in order to participate in and vote at the AGM is Friday, 29 January 2016.



17-Dec-2015
(Official Notice)
In compliance with section 3.59 of the JSE Limited Listings Requirements, and in terms of the subscription for shares agreement by Sanlam in Afrocentric Healthcare Assets (Pty) Ltd., a wholly owned subsidiary of AfroCentric, Sanlam are entitled to nominate two directors to the AfroCentric Board (?the Board?). Accordingly, the company is pleased to announce the appointment of Mr Ian Kirk and Mr Ahmed Banderker as Non-Executive Directors of AfroCentric with effect from 15 December 2015.



15-Dec-2015
(Official Notice)
The respective boards of ACT and Sanlam are confirmed that all the suspensive conditions relating to the Sanlam subscription, for the sum of R703 million, for a 28.7% interest in Afrocentric Healthcare Assets (Pty) Ltd. (?AHA?) a wholly owned subsidiary of Afrocentric (?the Transaction?), have been fulfilled or waived and the Transaction is now unconditional.



The effective date of the Transaction is today, 15 December 2015.



For ease of reference shareholders are referred to the detailed joint announcement published on the Stock Exchange News Service (?SENS?) on 30 September 2014 wherein they were advised of the full terms of the Transaction, and the subsequent announcements relating thereto.
08-Dec-2015
(Official Notice)
In compliance with section 3.59 of the JSE Limited Listings Requirements, the AfroCentric board of directors (?the Board?) wishes to announce the following changes.



Given the Company?s recent corporate actions and other changes to the Group?s corporate and operational structures, the Board have resolved to appoint a new Chief Executive Officer (?CEO?). Accordingly a change of role will occur in that Mr Dewald Dempers will step down as CEO with immediate effect.



Mr. Dempers will however continue to act as an Executive Director on the Board responsible for new growth opportunities, including inter alia, the promotion of business expected to arise through the Company?s recent developments and corporate actions.



The role of CEO will temporarily be filled by Non Executive Chairman, Dr. Anna Mokgokong while the company finalises the appointment of the new CEO. Shareholders are also advised that post a recent review of their classification on the Board, both Mr J.M.Kahn and Mr M.I. Sacks, previously Non-Executive Directors, are now classified as Independent Non-Executive Directors. Mr G.L. Napier will continue to serve as the Lead Independent Director.



The Board is also pleased to announce the appointment of Dr Nkateko David Munisi as a Non-Executive Director of the Board with effect from 7 December 2015.

03-Dec-2015
(Official Notice)
The Board of AfroCentric (?the Board?) wishes to advise, in compliance with the JSE Limited Listings Requirements, that Ms Lindani Dhlamini has been appointed as an Independent Non-Executive Director of the Board with effect from 2 December 2015.



22-Sep-2015
(C)
Revenue rose 7.15% to R2.1 billion (R2 billion). profit before income tax was up 13.40% at R279.4 million (R246.4 million), whilst total comprehensive income attributable to equity holders was R154.8 million (R153.8 million). In addition, headline earnings per share decreased to 38.43cps (47.83cps).



Dividend

The Board of Directors announced that in addition to the interim dividend already declared and paid for the year, a final dividend of 10 cents per ordinary share (gross) has been declared for the year ended 30 June 2015



Prospects

After several years of hard work in a fiercely competitive market, Afro-C have not only developed a successful and sustainable business, but in association with its new business partners, its new and expanding client base and the continuing improvements in system technologies, the Group is mindful of its opportunity for potential growth and expansion. While the Board is generally cautious about measuring future prospects, the developments recorded herein are encouraging features for the Group?s overall business going forward.
17-Sep-2015
(Official Notice)
Afrocentric shareholders (?Shareholders?) are referred to the trading statement announcement (?Trading Statement?) published on SENS on 10 September 2015. Due to a reclassification in the determination of Headline and Diluted headline earnings for the year ended 30 June 2015, the expected decline in Headline earnings and Diluted headline earnings per share, now falls between 16.4% and 20.6% (previously reported as a decline of between 23% and 27% in the Trading Statement).



Further to the above, the revised trading information is provided below.



Basic earnings in Rands for the year ended 30 June 2015 is likely to be marginally better than the comparative Rand earnings for the year ended 30 June 2014. Notwithstanding the aforesaid, this is the first full reporting period for which the fully dilutive impact of the 2014 share issues for the Preference Share Redemptions and Second Tranche Payments, will be applied.



As a result thereof, after taking into account the approximately 200 million more shares in issue during the period under review (being a 73% dilution in total issued shares and a 22% dilution in weighted average shares), the dilutive effect, on both Basic earnings and Diluted basic earnings per share and Headline earnings and Diluted headline earnings per share, has resulted in a decline in each case, and is expected to be between 15% and 20% for Basic earnings and Diluted basic earnings per share and between 16.4% and 20.6% for Headline earnings and Diluted headline earnings per share for the year ended June 2015.



The following guiding estimates are accordingly provided for the year ended 30 June 2015.



June 2015 range cents per Share* and June 2014 cents per Share

*Basic earnings -- 32.00 to 34.00; 40.00

*Diluted basic earnings -- 32.00 to 34.00; 40.00

*Headline earnings -- 38.00 to 40.00; 47.83

*Diluted headline earnings per share -- 38.00 to 40.00; 47.83



The Audited Annual Financial Results for the twelve months ended 30 June 2015 are expected to be published on or about 22 September 2015.
16-Sep-2015
(Official Notice)
Afro-C shareholders (?Shareholders?) are advised that Medscheme, a subsidiary of Afro-C Health Ltd. being a subsidiary of Afro-C, was awarded the POLMED administration and managed care contracts.



Medscheme currently administers over 20 medical schemes, including Bonitas and the Fedhealth open schemes as well as closed schemes for notable corporates which, amongst others, include Sasolmed, SABC, and AECI.
10-Sep-2015
(Official Notice)
The Company's Basic earnings in Rand for the year ended 30 June 2015 is likely to be marginally better than the comparative Basic earnings in Rand for the year ended 30 June 2014. Notwithstanding the aforesaid, this is the first full reporting period for which the fully dilutive impact of the 2014 share issues for the Preference Share Redemptions and Second Tranche Payments, will be applied.



As a result thereof, after taking into account the approximately 200 million more shares in issue during the period under review (being a 73% dilution in total issued shares and a 22% dilution in weighted average shares), the dilutive effect, on both Basic earnings and Diluted basic earnings per share and Headline earnings and Diluted headline earnings per share, has resulted in a decline in each case, and is expected to be between 15% and 20% for Basic earnings and Diluted basic earnings per share and between 23% and 27% for Headline earnings and Diluted headline earnings per share for the year ended June 2015.



The following guiding estimates are accordingly provided for the year ended 30 June 2015.

June 2015 range cents per Share - June 2014 cents per Share

* Basic earnings : 32.00 to 34.00 - 40.00

* Diluted basic earnings : 32.00 to 34.00 - 40.00

* Headline earnings : 35.00 to 37.00 - 47.83

* Diluted headline earnings per share : 35.00 to 37.00 - 47.83



The Audited Annual Financial Results for the year ended 30 June 2015 are expected to be published on or about 23 September 2015.
07-Sep-2015
(Official Notice)
AfroCentric shareholders (?Shareholders?) are referred to the announcements published by the Company on 30 September 2014 and 4 June 2015, as well as the circular dated 3 August 2015 (?Circular?) regarding the subscription by Sanlam Life Insurance Ltd., or its nominee, for shares in ACT Healthcare Assets (Pty) Ltd. (?AHA?), a wholly owned subsidiary of AfroCentric, representing 28.7% of the total issued share capital of AHA after such subscription for a cash amount of R703 million (?Sanlam Subscription?).



Results of general meeting

Shareholders are advised that at the general meeting of the Company held today, 7 September 2015 (?General Meeting?), the resolutions required to give effect to the Sanlam Subscription, as set out in the notice convening the general meeting incorporated in the Circular, were passed by the requisite majority of Shareholders without modification.



Conditions precedent to Sanlam subscription

Shareholders are referred to paragraph 2.3.1 of the Circular where the outstanding conditions precedent to the Sanlam Subscription were noted. Shareholders are advised that since the distribution of the Circular a number of conditions have been fulfilled including:

* the requisite Shareholder approval; and

* the necessary approval from the South African competition authorities.



Shareholders will be informed in due course regarding the fulfilment or waiver of the remaining conditions precedent.
03-Aug-2015
(Official Notice)
AfroCentric shareholders (?Shareholders?) are referred to the announcements published on the Stock Exchange News Service (?SENS?) on 30 September 2014 and 4 June 2015 wherein they were advised that AfroCentric had accepted an offer from Sanlam Ltd. (?Sanlam?) in terms of which Sanlam, or its nominee, would subscribe for a 28.7% interest in the issued share capital of ACT Healthcare Assets (Pty) Ltd., a wholly owned subsidiary of AfroCentric (?Transaction?).



A circular (?Circular?) has been posted to Shareholders today, 3 August 2015, containing, inter alia:

* details of the Transaction; and

* a notice convening a general meeting of Shareholders (?General Meeting?).



The Circular is also available for viewing on the Company?s website at http://www.afrocentric.za.com/sanlam-circular.php.



Shareholders are advised to review the Circular for a summary of the key terms and conditions of the Transaction.



Notice of General Meeting

The General Meeting will be held at AfroCentric Group Head Office, 37 Conrad Street, Florida North, Roodepoort on Monday, 7 September 2015 at 10:00 to consider and, if deemed fit, pass, with or without modification, the resolutions necessary to implement the Transaction.



Important dates and times

The salient dates and times relating to the General Meeting are set out in the timetable below (?Timetable?). Words and expressions in the Timetable and notes thereto shall have the same meaning as assigned to them in the Circular.

*Record Date for Shareholders to be recorded in the Register in order to receive this Circular on Friday, 24 July 2015

*Circular containing the Notice convening the General Meeting posted to Shareholders on Monday, 3 August 2015

*Last Day to Trade in Shares in order to be recorded in the Register to vote at the General Meeting on Friday, 21 August 2015

*Record Date for Shareholders to be recorded in the Register in Friday, 28 August 2015

*Forms of proxy for the General Meeting to be received by the Transfer Secretaries by 10:00 on Thursday, 3 September 2015

*General Meeting held at 10:00 on Monday, 7 September 2015

*Results of the General Meeting published on SENS on Monday, 7 September2 015
31-Jul-2015
(Official Notice)
In compliance with Rule 3.59 of the JSE Ltd. Listings Requirements, the Company wishes to make the following announcement.



The board of directors of Afro-C (?the Board?) announced that Mr Wallace Holmes, who has reached the mandatory retirement age, has retired as the Group Chief Financial Officer (?CFO?) with effect from 1 August 2015.



The Chairman and the Board wish to thank Wallace for his valued contribution to the Company during his tenure on the Board and wish him well going forward.



Mr Hannes Boonzaaier has been appointed as an Executive Director and Group CFO with effect from 1 August 2015.



Hannes qualified as a CA (SA) after completing his articles with KPMG in 1999. He then joined the Corporate Finance team at KPMG where he gained experience in valuations, due diligence reviews and commercial structuring of deals. After 3 years in the Corporate Finance environment, he joined the Medscheme group as a financial manager. In 2010 after the Afro-C purchase of the Lethimvula Group, Hannes was appointed as the General Manager for group financial reporting. His success in leading the financial team and the core business knowledge gained by him resulted in his appointment as CFO from 1 March 2015 for Afro-C Health Ltd., which is the largest subsidiary in Afro-C.



Mr Willem Britz has been appointed as an Executive Director of the Company with effect from 1 August 2015.



As one of the founding members of WAD Holdings, Willem Britz is an admitted attorney and has been involved in numerous business ventures ranging from mining to pharmaceutical, financial services, property, telecommunications and the game breeding industry over the past 12 years. He also acted as an advisor to the medical aid industry for several years.



The Chairman and the Board wish to welcome Hannes and Willem to the Board and know that they will make a positive contribution to the ongoing success of the Company.
04-Jun-2015
(Official Notice)
30-Mar-2015
(C)
Revenue for the interim period increased to R1.016 billion (2013: R937.2 million). Operating profit rose to R173.2 million (2013: R144.7 million), while profit attributable to equity holders of Afro-C was higher at R94.8 million (2013: R71.2 million). Furthermore, headline earnings per share decreased to 21.84cps (2013: 26.09cps).



Dividend

The Board of Directors announced that the Company?s first interim dividend of 10cps has been declared for the six months ended 31 December 2014.



Prospects

While economic indicators in South Africa at this time suggest a challenging period ahead, it is nevertheless expected that the principal business of the Group will continue to generate positive outcomes, particularly given that the acquisition of WAD and the strategic investment by SANLAM will significantly expand the Group?s capital base and positively position the Group for further growth.
02-Mar-2015
(Official Notice)
AfroCentric announced that Ms Shireen Lutchan has been appointed as the Group Company Secretary with effect from 1 March 2015.
29-Jan-2015
(Official Notice)
Shareholders were advised that Mr Wilbert Mhlanga has resigned as Company Secretary with effect from 31 January 2015. A further announcement will be issued to shareholders, in due course, regarding the appointment of a new Company Secretary.
21-Jan-2015
(Official Notice)
The board of directors of Afrocentric hereby advises that at the Annual General Meeting of shareholders held on Wednesday, 21 January 2015, the resolutions, as set out in the notice of Annual General Meeting which was incorporated in the Integrated Annual Report distributed to shareholders on 15 December 2014 were duly approved by the requisite majority of shareholders present (in person or represented by proxy) and voting.
15-Dec-2014
(Official Notice)
Shareholders of AfroCentric (?Shareholders?) are hereby advised that the audited annual financial statements of the company for the year ended 30 June 2014, as contained in the integrated annual report 2014 (?Integrated Report?), will be posted to Shareholders today, 15 December 2014, and contain no modifications to the audited results which were published on SENS on 30 September 2014.



Notice of annual general meeting

Notice is hereby given that the annual general meeting of the company will be held on Wednesday, 21 January 2015, at 10h00 at The Bonitas Marketing company Offices, the Greens Office Park, Building L, 26 Charles De Gaulle Crescent, Highveld Ext 12, Centurion to transact the business as set out in the notice of annual general meeting, which forms a part of the Integrated Report.



Record date

The date on which Shareholders of the company must be recorded as such in the company's securities register in order to attend and vote at the annual general meeting is Friday, 16 January 2015, with the last day to trade being Friday, 9 January 2015.



Proxy forms must be lodged by no later than 10:00 on Monday, 19 January 2015.
30-Sep-2014
(C)
Revenue rose 10.62% to R2 billion (R1.8 billion) whilst operating profit increased by 6.8% to R356.4 million (R333.7 million). Total comprehensive income attributable to equity holders was R153.8 million (R163.6 million). In addition, headline earnings per share increased to 47.83cps (48.15cps).



Dividend

The board of directors has pleasure in announcing that a dividend of 18 cents per ordinary share (gross) has been declared for the year ended 30 June 2014.



Prospects

Apart from the Group?s consistent past trends of growth, both transactions referred to herein, expand the Group?s value proposition for all stakeholders, materially enhances its marketing and distribution channels, significantly expands its capital base and positively positions the Group for accelerated growth.
30-Sep-2014
(Official Notice)
30-Sep-2014
(Official Notice)
11-Sep-2014
(Official Notice)
Management has always been of the view that diluted earnings and diluted headline earnings per share provides the most relevant measurement for the group's operational performances, particularly in this period, given the number of shares issued during the year for the second tranche payments and the redemption of the Preference shares. The following guiding estimates are accordingly provided for the year ended 30 June 2014.



June 2014 Guidance - June 2013 cents per share:

* Diluted headline earnings: 65% to 70% increase - 28.62

* Diluted basic earnings: 10% to 12 % increase - 36.11

* Headline earnings: 0% to 2% decrease - 48.15

* Basic earnings: 30% to 35% decrease - 60.75



The Audited Annual Financial Results for the year ended 30 June 2014 are expected to be published on or about 30 September 2014.
03-Sep-2014
(Official Notice)
Afro-C shareholders are referred to the cautionary announcements dated 23 July 2014 and 10 June 2014 and are advised that the discussions referred to therein are continuing and, if successful, may have a material effect on the price of AfroCentric securities. Shareholders are accordingly advised to continue to exercise caution when dealing in the Company's securities until a further announcement is made.
23-Jul-2014
(Official Notice)
Afro-C shareholders are referred to the cautionary announcement published in the press on 10 June 2014 and are advised that the discussions referred to therein are ongoing and, if successful, may have a material effect on the price of the Company?s securities.



Accordingly shareholders are advised to continue to exercise caution when dealing in AfroCentric securities until a further announcement is made.
03-Jul-2014
(Official Notice)
The board of Afro-C advised, in compliance with the JSE Ltd. Listings Requirements, that Mr Garth Napier, who is currently an Independent Non-Executive Director for Afro-C has been appointed as the Lead Independent Non-Executive Director for Afro-C with effect from 2 July 2014.
10-Jun-2014
(Official Notice)
Afrocentric shareholders are advised that the company has entered into discussions which, if successful, may have a material effect on the price of the company's securities.



Accordingly shareholders are advised to exercise caution when dealing in Afrocentric securities until a further announcement is made.
09-Jun-2014
(Official Notice)
The board of Afro-C advised, in compliance with the JSE Ltd. Listings Requirements, that Mr Kevin Aron has been appointed as Chief Executive Officer of Medscheme Holdings (Pty) Ltd, with effect from 1 July 2014.
24-Mar-2014
(C)
Revenue for the interim period increased by 14% to R937.2 million (2012: R822.4 million). Operating profit grew to R144.7 million (2012: R135.2 million), while profit attributable to equity holders of the parent rose by 20% to R71.2 million (2012: R59.5 million). Furthermore, headline earnings per share was higher at 26.09cps (2012: 21.92cps).



Dividends

The policy of the Board is to review profits available for distribution to shareholders at the end of each financial year. Accordingly no distribution has been considered at this time.



Prospects

The high level attainment of the profit warranty provides a sense of reassurance on the earning capacity of the Group's principle subsidiary AHL. These interim results reflect the continuing growth pattern of profits after tax. Additional shares have been issued, both under the second tranche payment provisions and the preference share redemptions, the effect of which could have a dilutionary impact on the basic and headline earnings per share going forward. Notwithstanding the aforesaid, there exists a reasonably secure foundation for the health-related portfolio businesses. Having regard to the marginal profits of Jasco in this period the Group remains vigilant of its performance and will seek to support the company in its intended disposal of its investment in M-Tec.
24-Mar-2014
(Official Notice)
The board of Afro-C advised that Afro-Cc has appointed SizweNtsalubaGobodo Inc and PricewaterhouseCoopers Inc as the Company's joint external auditors for the financial year ending 30 June 2014.
03-Mar-2014
(Official Notice)
The board of Afro-C advised, in compliance with the JSE Limited Listings Requirements, that Mr Brian Joffe has resigned as non-executive director of the Company with effect from 03 March 2014.
24-Jan-2014
(Official Notice)
Shareholders are advised that all of the ordinary and special resolutions proposed at the AGM held on 23 January 2014 were approved by the requisite number of shareholders with the following exceptions:



Ordinary resolution number 6.1 regarding the re-appointment of the independent registered auditor was not passed; and



Ordinary resolution number 8.1 regarding the appointment of Mr MI Sacks to the Audit Committee, was withdrawn prior to the AGM, however Mr MI Sacks was re-appointed as a member of the board.



The special resolutions, where applicable, will be filed with the Companies and Intellectual Property Commission in due course.
03-Jan-2014
(Official Notice)
Afro-C Preference Shareholders are referred to a circular that was mailed to them on Monday, 28 October 2013 and to the announcement released on SENS on Friday, 1 November 2013 regarding the exercise of Call Options and redemption and delisting of all of the Preference Shares in issue. The election period closed at 12h00 on Friday, 15 November 2013 for certificated Preference Shareholders and at 12h00 on Tuesday, 31 December 2013 for dematerialised Preference Shareholders.



Results of the election

Afro-C Preference Shareholders are advised that Preference Shareholders holding 99.68% Preference Shares have exercised their Call Options in respect of the Redeemable Preference Shares held by them. Afro-C will redeem the Redeemable Preference Shares in respect of which the Call Options have been exercised by issuing 69 981 412 New Ordinary Shares in aggregate to such Preference Shareholders on Friday, 3 January 2014.



Preference Shareholders who exercised their Call Options in part or did not elect to exercise their Call Options timeously, are reminded that the rights of the Preference Shareholder concerned automatically lapsed with effect from close of trading on Tuesday, 31 December 2013. Such Preference Shareholders will have their relevant Redeemable Preference Shares redeemed on Monday, 6 January 2014 against payment of the Redemption Price of R0.91 per Preference Share.



All of the Redeemable Preference Shares in issue will be delisted from the JSE at the close of trading on Monday, 6 January 2014.
06-Dec-2013
(Official Notice)
Shareholders are advised that the Annual Financial Statements of the Company for the year ended 30 June 2013 will be posted to shareholders today, 6 December 2013 and contain no modifications to the audited results which were released on SENS on 27 September 2013.



Notice of annual general meeting

Notice is hereby given that the annual general meeting of the Company will be held at AfroCentric Head Office, 11th Floor, Sandton City Towers, Sandton City, Sandton on 23 January 2014 at 12h00 to transact the business as stated in the annual general meeting notice, forming part of the Annual Financial Statements.



Record dates

The notice of annual general meeting will be posted to shareholders of the Company who were recorded as such in the Company's securities register on Friday, 29 November 2013. The last day to trade in order to be eligible to attend and vote at the Annual General Meeting will be Friday, 10 January 2014. The date on which shareholders of the Company must be recorded as such in the Company's securities register in order to attend and vote at the annual general meeting is Friday, 17 January 2014. Proxy Forms must be lodged by no later than 12:00 on Wednesday, 22 January 2014.
14-Nov-2013
(Official Notice)
The board of AfroCentric wishes to advise that Andre Meyer has resigned as Chief Executive Officer of Medscheme Holdings (Pty) Ltd., a major subsidiary of AfroCentric, with effect from 28 February 2014.
01-Nov-2013
(Official Notice)
29-Oct-2013
(Official Notice)
Shareholders are advised that a circular was posted on Monday, 28 October 2013 to AfroCentric Preference Shareholders regarding the exercise of Call Options and redemption and delisting of 16 638 000 Redeemable Preference Shares of R0.91 each in the issued capital of the company.



A copy of the circular will also be made available on the company's website www.afrocentric.za.com.



Salient dates and times

The salient dates in respect of the Call Option and redemption of the AfroCentric Preference Shares are set out below. Any changes to these dates will be announced on SENS.

*Record date for Preference Shareholders to receive the circular -- Friday, 18 October 2013

*Post Circular and forms of exercise and surrender to Preference Shareholders -- Monday, 28 October 2013

*Announce finalisation information -- Friday, 1 November 2013

*Contingent Ordinary Shares and Executive Share Awards listed on the JSE -- Thursday, 14 November 2013

*Record date for exercise by Certificated Preference Shareholders of Call Option -- Friday, 15 November 2013

*Certificated Preference Shareholders election date at 12h00 to be issued with New Ordinary Shares -- Friday, 15 November 2013

*Last day to trade for Dematerialised Preference Shareholders in order to exercise Call Options -- Friday, 20 December 2013

*Last day to trade for Redemption of Preference Shares -- Friday, 20 December 2013

*Preference shares suspended as from commencement of trade -- Monday, 23 December 2013

*Listing of maximum number of new ordinary shares in respect of Preference Shares call option exercised -- Tuesday, 24 December 2013

*Record date for exercise by Dematerialised Preference Shareholders of Call Option and for redemption -- Tuesday, 31 December 2013

*Dematerialised Preference Shareholders election date at 12h00 to be issued with New Ordinary Shares -- Tuesday, 31 December 2013

*Call Options lapse (17h00) -- Tuesday, 31 December 2013

*Results of election announced on SENS -- Friday, 3 January 2014

*Issue of New Ordinary Shares -- Friday, 3 January 2014

*Payment date of Redemption Price -- Monday, 6 January 2014

*Redeemable Preference Shares delisted at close of trading -- Monday, 6 January 2014

Note: Share certificates may not be dematerialised or rematerialised after 20 December 2013.
11-Oct-2013
(Official Notice)
27-Sep-2013
(C)
Revenue rose 22.2% to R1.8 billion (R1.4 billion) whilst operating profit increased by 28.7% to R333.7 million (R259.3 million).Profit attributable to equity holders was R163.6 million (R164.5 million). In addition, headline earnings per share decreased to decreased to 48.15cps (55.67cps).



Dividend

The Board of Directors announced that a dividend of 15 cents per ordinary share (gross) (10.5 cents) has been declared for the year ended 30 June 2013.



Prospects

Now that the acquisition of AHL (Lethimvula) is virtually finalised, shareholders can take comfort from the fact that AHL has developed into a significant player in the private health-care industry, a company with a proven business model, a sound, experienced and talented management team and a track record revealing a sustainable and impressive growth trend in earnings. It was gratifying, but not entirely surprising, that this black-controlled Group, was recently recognised by the Financial Mail/Accenture and rated fourth best company for 2013. In retrospect, given the profits of AHL for 2013, at R250 million after tax, the eventual purchase price paid for AHL calculates at a PE ratio of less than 4 times earnings.



The Group's investment in Jasco has been unfortunate, the effect though, arising substantially through the poor performance and impairment of M-Tech. The decision to categorise M-Tech as an asset for sale may well be the right decision. M-Tech has a substantial production capacity and net asset value and its fortunes could easily be reversed in the right economic circumstances.



The Group's balance sheet is largely ungeared, its cash flows have always been strong and the Board remains confident in the Group's positive direction for 2014.
25-Sep-2013
(Official Notice)
19-Sep-2013
(Official Notice)
Shareholders were advised that Mr Joe Applegryn has been appointed as Non-Executive director with effect from 17 September 2013.
04-Jun-2013
(Official Notice)
Further to the announcement of 19 October 2012, the board of AfroCentric announced the appointment of Statucor (Pty) Ltd. as Company Secretary as of 3 June 2013.
12-Mar-2013
(C)
Revenue for the interim period ended 31 December 2012 shot up by 22.75% to R822.4 million (2011: R670 million). Operating profit surged by 31% to R135.2 million (2011: R103.2 million), while profit attributable to equity holders of the parent rose by 9.54% to R59.5 million (2011: R54.3 million). Furthermore, headline earnings per share grew by 7.63% to 21.92cps (2011: 20.37cps).



Dividends

The policy of the Board is to review profits available for distribution to shareholders at the end of each financial year. Accordingly no distribution has been considered at this time.



Prospects

While the Group's investment in AHL has generally been heartening, the progress and performance of Jasco during the period under review has been disappointing. The board nevertheless recognises the talent and commitment of both management teams, and remains confident of the growth prospects of each of the core businesses. The Board will proceed to assess new opportunities which satisfy the criteria of the Board Investment Committee, including providing continual counsel to group management on operational matters and efficiencies.
14-Feb-2013
(Official Notice)
Shareholders were advised that all of the ordinary and special resolutions proposed at the AGM of Afrocentric held on 13 February 2013, were approved by the requisite number of shareholders. The special resolutions, where applicable, will be filed with the Companies and Intellectual Property Commission in due course.
20-Dec-2012
(Official Notice)
Shareholders are advised that the Annual Financial Statements of the Company for the year ended 30 June 2012 will be posted to shareholders on 21 December 2012 and contain no modifications to the audited results which were released on SENS on 27 September 2012.



Notice of annual general meeting

Notice is hereby given that the annual general meeting of the Company will be held at 37 Conrad Drive, Florida North, Roodepoort, Gauteng on Wednesday, 13 February 2013 at 10h00 to transact the business as stated in the annual general meeting notice, forming part of the Annual Financial Statements.
19-Oct-2012
(Official Notice)
Shareholders were advised that the following changes to the company secretary:



The board advised that Mr Shayne Ablett, who has been acting in the capacity of company secretary has resigned from the company.



An announcement will be made in due course in connection with the appointment of a Company Secretary and until that time Ms Yolandi van Zweel, currently General Manager responsible for Legal, Governance, Risk and Compliance of the Group, act in that capacity with immediate effect.
12-Oct-2012
(Official Notice)
The audited annual results for the year ended 30 June 2012 were released on SENS on 27 September 2012 and published in the press on 28 September 2012. Information on the dividend declaration was deferred at the time pending confirmation of the extent of Secondary Tax on Companies (STC) credits being available.



The board of directors have therefore announced that a dividend of 10.5 cents per ordinary share (gross) and 29.8 cents per preference share (gross) has been declared for the year ended 30 June 2012. The salient dates relating to both the ordinary and preference dividends are as follows;

*Last day to trade cum dividend -- Friday, 7 December 2012

*Shares commence trading ex dividend -- Monday, 10 December 2012

*Dividend record date -- Friday, 14 December 2012

*Dividend payment date -- Tuesday, 18 December 2012
27-Sep-2012
(C)
Revenue increased to R1.45 billion (R1.35 billion). Operating profit rose 16.2% to R259.3 million (R223.1 million). Net attributable profit improved to R164.5 million (R117.2 million). In addition, headline earnings per share grew 16% to 55.67cps (47.98cps).



Outlook

The principal investments of the group, AHL and Jasco compete in industries that have traditionally been controlled by some of South Africa's largest Institutions. For AfroCentric, substantially a Black controlled "start up" investment group, to have secured a foothold in each case, begins to reveal a transformational adoption and market confidence in the values and professionalism that characterise the group's skills and efficiencies, as well as the affordability of and belief in its products and services. The board has great confidence in each of the group's teams of management and would be more than satisfied with a recurring level of growth going forward.
21-Sep-2012
(Official Notice)
AfroCentric shareholders are accordingly advised that:

Basic earnings per share (EPS) for the year ended 30 June 2012 is expected to be between 30% and 40% higher compared to the EPS for the year ended 30 June 2011. Headline earnings per share (HEPS) for the year ended 30 June 2012 is expected to be between 15% and 20% higher compared to the HEPS for the year ended 30 June 2011.



The financial information on which this trading statement is based has not been reviewed or reported on by AfroCentric's auditors. The results for the year ended 30 June 2012 are expected to be published on or about 28 September 2012.
10-Sep-2012
(Official Notice)
Shareholders were advised that the following changes to the board of directors and officers are effective immediately:

*Ms Brigalia Bam has advised the company that she wishes to retire as non-executive chairperson. Ms Bam will however remain on the board as a non-executive director.

*The board advised that Dr Anna Mokgokong has

been appointed non-executive chairperson of the board. Dr

Mokgokong has been a Director of AfroCentric since June 2010.



Shareholders are further advised that Michael (Motty) Sacks has retired as company secretary. Mr Sacks will however remain on the board as a non-executive director. An announcement will be made in due course in connection with the appointment of a company secretary and until that time Mr Shayne Ablett, the current company secretary of AfroCentric Health Ltd. will act in that capacity.



Finally, the board announced that Mr Dewald Dempers, presently the CEO of AfroCentric Health has been appointed as AfroCentric group CEO. Dewald Dempers.
14-Mar-2012
(C)
Revenue for the interim period decreased to R670 million (2010: R672.1 million), but operating profit rose to R103.2 million (2010: R92.4 million), while profit attributable to equity holders of the parent increased to R54.3 million (2010: R46.7 million). Furthermore, headline earnings per share continued the growth trend by rising to 20.37cps (2010: 18.09cps).



Dividend

The policy of the board is to review profits available for distribution to shareholders at the end of each financial year. Accordingly no distribution has been considered at this time.



Prospects

The board maintains a regular review of the activities of the group's current investment portfolio. The board is satisfied with the progress in each case and given the gradual improvement in market conditions and confidence, will continue to assess opportunities which satisfy the criteria of the Board Investment Committee.
04-Nov-2011
(Official Notice)
Shareholders are referred to the audited group results announcement dated 27 September 2011 wherein it was stated that the board of directors had declared a cash distribution in the form of a capital reduction out of share premium of 9 cents per ordinary share. Preference shareholders participate in distributions on the basis that they are entitled to 15% of the aggregate distribution payable to preference and ordinary shareholders. Having regard thereto, a cash distribution of 25.48 cents per preference share has been declared in terms of the company's Memorandum of Incorporation. The company has determined the following salient dates for the payment of the cash distributions for ordinary and preference shareholders.

*Last day to trade "cum" the cash distributions -- Friday, 18 November 2011

*Ordinary shares and preference shares commence trading "ex" the cash distributions -- Monday, 21 November 2011

*Record date to participate in the cash distributions -- Friday, 25 November 2011

*Payment date for ordinary and preference shareholders in respect of the cash distributions -- Monday, 28 November 2011

No ordinary or preference share certificates may be dematerialised or rematerialised between Monday, 21 November 2011 and Friday, 25 November 2011 both days inclusive.
27-Sep-2011
(C)
Revenue declined to R1 351.3 million (R1 356.3 million). Net attributable profit surged to R117.2 million (loss of R7.4 million). In addition, headline earnings jumped to 47.98cps (28.17cps).



Dividend

A final cash distribution of 9cps out of share premium has been declared.



Outlook

The board has consistently adopted a cautious approach to the approval of new acquisitions. However, the positive trend in profitability and the renewed growth potential in each of the group's more material investments has already prompted the investment committee to consider further investment opportunities.
16-Sep-2011
(Official Notice)
AfroCentric is currently finalising its results for the financial year ended 30 June 2011 which are due to be released on SENS on 27 September 2011 and published in the press on 28 September 2011. Shareholders were advised that the company's basic reported earnings per share (EPS) and diluted basic EPS for the financial year ended 30 June 2011 will be between 1840% and 1860% higher than that reported for the previous corresponding reporting period. Headline earnings per share (HEPS) and diluted HEPS will be between 65% and 75% higher than that reported for the previous corresponding reporting period.
05-Aug-2011
(Official Notice)
The AfroCentric board identified a number of excellent candidates for selection and, after a rigorous process, have appointed two exceptional individuals to join the board. The board of Afrocentric is pleased to advise that Mrs Yasmin Masithela and Mr Garth Napier have been appointed as independent non- executive directors of the company with effect from 1 September 2011.



29-Mar-2011
(C)
Revenue for the interim period decreased to R672.1 million (2009: R682.7 million), but operating profit soared by 86% to R92.4 million (2009: R49.7 million), while profit attributable to equity holders of the parent rocketed by 250% to R46.7 million (2009: R13.4 million). Furthermore, headline earnings per share continued the strong growth trend by surging to 18.09cps (2009: 6.86cps).



Dividend

The group declared its maiden distribution, in the form of a capital reduction out of share premium, of 7.5cps for the year ended 30 June 2010. The board will consider further distributions based on the performance of the group for the year ending 30 June 2011.



Prospects

The board has deliberately and consistently adopted a cautious approach in the past to the approval of new acquisition opportunities, preferring to secure the growth and sustainability of its existing investments. However, the profitability and renewed potential for growth of the more material investments in the portfolio will no doubt inspire the investment committee and the board to give serious attention to further investment propositions which are regularly presented for consideration.
10-Mar-2011
(Official Notice)
AfroCentric shareholders are accordingly advised that:

*Earnings per share ("EPS") and diluted EPS for the six months ended 31 December 2010 are expected to be between 240% and 260% higher compared to the EPS for the six months ended 31 December 2009.

*Headline earnings per share ("HEPS") and diluted HEPS for the six months ended 31 December 2010 are expected to be between 160% and 180% higher compared to the HEPS for the six months ended 31 December 2009.

*The financial information on which this trading statement is based has not been reviewed or reported on by AfroCentric's auditors. The results for the six months ended 31 December 2010 are expected to be published on or about 18 March 2011.
21 Dec 2010 14:37:22
(Official Notice)
Shareholders are referred to the audited Group results announcement dated 29 September 2010 wherein it was stated that the board of directors had proposed the Group's maiden distribution in the form of a capital reduction out of share premium of 7.5 cents per ordinary share, subject to shareholder approval at the Annual General Meeting on 15 December 2010, which approval has been obtained. Preference shareholders participate in distributions on the basis that they are entitled to 15% of the aggregate distribution payable to preference and ordinary shareholders ("the capital distribution").



Holders of AfroCentric preference shares are advised that a payment by way of a capital reduction out of the Company's share premium account of 21.08 cents per preference share has been declared in terms of the Company's Articles of Association. In compliance with the requirements of Strate, the electronic settlement custody system used by the JSE Limited, the Company has determined the following salient dates for the payment of the capital distribution for ordinary and preference shareholders.

*Last day to trade "Cum" the capital distribution Friday,7 January 2011

*Ordinary and preference shares trade Monday, 10 January 2011 "Ex" "capital distribution"

*Record date to participate in the capital distribution Friday, 14 January 2011

*Payment date to shareholders in respect of the capital distribution Monday, 17 January 2011

*No ordinary and preference share certificates may be dematerialised or rematerialised between Monday, 10 January 2011 and Friday, 14 January 2011, both dates inclusive.
15 Dec 2010 15:50:12
(Official Notice)
Shareholders are advised that, at the company's annual general meeting held at 10h00 on Wednesday, 15 December 2010 the special resolution and all the ordinary resolutions, proposed thereat, were approved by the requisite majority of shareholders. The special resolution will be lodged for registration with the Companies and Intellectual Property Registration Office in due course.
25 Nov 2010 18:39:13
(Official Notice)
Shareholders are referred to page 81 of the Notice of the AGM included in the Annual Report for the year ended 30 June 2010 posted to shareholders on Wednesday, 24 November 2010.The date of the AGM was incorrectly stated as Monday, 15 December 2010 and should have read Wednesday, 15 December 2010. The correct details of the AGM are available for viewing on the company's website at www.afrocentric.za.com.
24 Nov 2010 16:35:58
(Official Notice)
Shareholders are advised that the Annual Financial Statements of the company for the year ended 30 June 2010 will be posted on 24 November 2010 and contain no modifications to the audited financial results which were released on SENS on Wednesday, 29 September 2010.



Notice is hereby given that the annual general meeting of the company will be held in the Imvula boardroom, Medscheme 10 Muswell Road South, Bryanston, on Wednesday, 15 December 2010 at 10h00 to transact the business as stated in the annual general meeting notice, forming part of the Annual Financial Statements.

29 Sep 2010 08:26:49
(C)
Revenue increased to R1.4 billion (June 2009: R520 million). Profit before taxation decreased to R15.7 million (June 2009: R66.5 million). Loss attributable to ordinary shareholders was recorded at R7.4 million (June 2009:Profit of R34.7 million). Headline earnings per share grew to 29.78cps (June 2009: 18.37cps).



Distributions

The board of directors has proposed the group's maiden distribution in the form of a capital reduction out of share premium of 7,5 cents per ordinary share, subject to shareholder approval at the annual general meeting. Preference shareholders participate in distributions on the basis that they are entitled to 15% of the aggregate distribution payable to preference and ordinary shareholders. All the salient dates and times for the ordinary shares and the preference shares will be announced once the annual general meeting has been held and shareholders' approval has been given.



Prospects

The board of directors is satisfied with the progress of AfroCentric for the past year and the group's sound platform for future earnings. During the past three months, there seems to be a greater degree of business confidence developing in South Africa and the Board Investment Committee will continue to consider new investment propositions that are presented. While trends are encouraging, it is too early to judge whether the growth in earnings and the profit warranty thresholds in the LIL acquisition will be fulfilled. In the meantime, LIL continues to trade in a robust manner and consistent with our estimates and expectations at the time of acquisition.
28 Sep 2010 17:15:31
(Official Notice)
Further to the SENS announcement published on 22 September 2010, shareholders are advised that AfroCentric is currently finalising its results for the year ended 30 June 2010. Accordingly, a review of the financial results for the year ended 30 June 2010, has indicated that a final audit adjustment has marginally impacted on the basic loss per share and the diluted basic loss per share for the financial year ended 30 June 2010. The basic earnings per share ("EPS") and basic diluted earnings per share will now be between 85% and 115% lower than that reported for the previous corresponding period. Notwithstanding this dramatic impact on the company's basic EPS, headline earnings per share ("HEPS") and diluted HEPS will remain unchanged between 50% and 70% higher than that reported for the previous corresponding reporting period.
22 Sep 2010 16:21:15
(Official Notice)
Shareholders are referred to the AfroCentric circular distributed to Lethimvula Investments Limited ("LIL") shareholders dated 27 February 2009. Paragraph 19 of that circular, captioned "Material Changes", records reference to the agreements concluded by LIL for the acquisition of Old Mutual Healthcare (Proprietary) Limited ("OMHC") and at the same time, but independently, the disposal by a LIL subsidiary, Medscheme Limited, of its interest in Medscheme Life Assurance Limited to Old Mutual South Africa Limited. The regulatory approvals for these transactions were received towards the end of the 2009 financial year and during the 2010 financial year. Accordingly, in terms of IFRS 3, restructuring and retrenchment costs are recognised in the consolidated income statement in the 2010 financial year.



Having regard to the above and certain other amortisation and impairments, shareholders are advised that the company's basic reported earnings per share (EPS) and diluted basic EPS for the financial year ended 30 June 2010 will be between 80% and 100% lower than that reported for the previous corresponding reporting period. Notwithstanding this dramatic impact on the company's basic EPS, headline earnings per share (HEPS) and diluted HEPS will be between 50% and 70% higher than that reported for the previous corresponding reporting period. The financial information on which this trading statement is based, has not been reviewed by the company's auditors.

23 Jun 2010 15:17:43
(Official Notice)
AfroCentric is pleased to announce the appointment of Mr Wallace Holmes to the board of directors as group executive financial director with immediate effect. Mr Holmes replaces Michael Sacks who resigned as financial director of the company with effect from 23 June 2010. Mr Sacks will however continue to serve as a non-executive director and company secretary.
10 Jun 2010 17:13:13
(Official Notice)
Shareholders will be aware that with effect from 23 March 2010 the listing of AfroCentric ordinary shares and AfroCentric preference shares were moved from the Food Producers - Farming and Fishing Sector to the Healthcare Sector list. This became necessary and appropriate to reflect the weighted nature of the company's more material investments in the healthcare sector and the more likely expansion of its healthcare assets and technologies. The board of directors has also been restructured and shareholders are advised that Prof Derrick Swartz, Mr Mandla Gantsho and Ms Nomhle Canca have tendered their resignations as non-executive directors with effect from 19 May 2010, 31 May 2010 and 2 June 2010 respectively and Dr. Anna Mokgokong and Mr. Joe Madungandaba have been appointed as non-executive directors to the board with immediate effect.
26 Mar 2010 16:47:44
(C)
Revenue amounted to R682.7 million for the six months ended 31 December 2009. Operating profit came in at R79.8 million, compared to a loss of R1.4 million previously. Net attributable profit more than doubled to R19.2 million (R8.8 million). In addition, headline earnings per share increased by 49.5% to 9.11 cps (6.09 cps).



Dividends per share

No interim dividend was declared for the period under review.



Outlook

The board investment committee will maintain the principles of the existing investment policy on all new propositions and will continue to provide advice and direction to management in each case. Since 31 December 2009 there are a few encouraging signs of recovery in market conditions in South Africa and notwithstanding the challenges the country faces on a number of fronts, there are some signs which suggest that the various business units within the investment portfolio will positively extract value from any improved circumstances.

23 Mar 2010 11:05:02
(Official Notice)
Earnings per share (EPS) for the six months ended 31 December 2009 are expected to be between 20% and 30% higher compared to the EPS for the six months ended 31 December 2008. Headline earnings per share (HEPS) for the six months ended 31 December 2009 are expected to be between 45% and 55% higher compared to the HEPS for the six months ended 31 December 2008. The results for the six months ended 31 December 2009 are expected to be published on or about 26 March 2010.
18 Jan 2010 12:44:58
(Official Notice)
At the annual general meeting of AfroCentric held on 18 January 2010, all the resolutions proposed thereat were passed by the requisite majority of shareholders.
17 Dec 2009 09:26:35
(Official Notice)
Shareholders are advised that the annual financial statements of the company for the year ended 30 June 2009 will be posted on 28 December 2009 and contain no modifications to the audited financial results which were published on SENS on Tuesday, 29 September 2009. Notice is hereby given that the annual general meeting of the company will be held in the executive boardroom, Medscheme 10 Muswell Road South, Bryanston, on Monday, 18 January 2010 at 10h00 to transact the business as stated in the annual general meeting notice, forming part of the annual financial statements.
29 Sep 2009 12:08:25
(C)
Revenue increased to R519.8 million in 2009. Profit before taxation rose to R66.5 million (2008:R13.4 million). Profit attributable to ordinary shareholders increased to R34.7 million (R10.8 million). Headline earnings on a per share basis grew to 18.37cps (11.04cps).



Dividends per share

No final dividend was declared for the period under review.



Prospects

The board of directors were satisfied with the progress of AfroCentric for the year and the company's sound platform for future earnings. Having regard to the current economic climate, the board investment committee will continue to apply the rigid principles of its investment policy, regularly monitoring the progress of each enterprise and guiding and supporting management in each case on matters of strategy, new products and expansion. A regular deal flow continues to receive the attention of the board investment committee and several propositions are currently being evaluated. It is too early to judge whether the growth in earnings and profit warranty thresholds in the Lethimvula acquisition will be fulfilled, but given the five month performance of Lethimvula, and the new business growth disclosed herein, including the efficiencies of greater scale and specialisation, the board is encouraged by the early and positive trend and direction. Absent some unexpected event or regulatory intervention, Lethimvula and its subsidiary, Medscheme, will become a leading enterprise in healthcare administration.
25 Sep 2009 15:52:33
(Official Notice)
Shareholders are referred to the trading statement released on SENS on 15 September 2009. During the course of the audit process, certain adjustments became necessary in terms of IFRS 3 in respect of the acquisition of Lethimvula Investments Ltd subsequent to the trading statement at 15 September 2009. In light of the above, AfroCentric shareholders are accordingly advised that:

*Earnings per share (EPS) for the year ended 30 June 2009 are expected to be between 70% and 80% higher compared to the EPS for the year ended 30 June 2008. It was previously reported that EPS would be between 80% and 90% higher compared to the EPS for the year ended 30 June 2008.

*Headline earnings per share (HEPS) for the year ended 30 June 2009 are expected to be between 60% and 70% higher compared to the HEPS for the year ended 30 June 2008. It was previously reported that HEPS would be between 70% and 80% higher compared to the HEPS for the year ended 30 June 2008.



The results for the year ended 30 June 2009 are expected to be published on or about 29 September 2009.
15 Sep 2009 15:38:30
(Official Notice)
AfroCentric shareholders are accordingly advised that:

*EPS for the year ended 30 June 2009 are expected to be between 80% and 90% higher compared to the EPS for the year ended 30 June 2008.

*HEPS for the year ended 30 June 2009 are expected to be between 70% and 80% higher compared to the HEPS for the year ended 30 June 2008.

*Diluted EPS for the year ended 30 June 2009 are expected to be between 100% and 110% higher compared to the diluted EPS for the year ended 30 June 2008.

*Diluted HEPS for the year ended 30 June 2009 are expected to be between 90% and 100% higher compared to the diluted HEPS for the year ended 30 June 2008.



The results for the year ended 30 June 2009 are expected to be published on or about 25 September 2009.
01 Jun 2009 15:25:57
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the announcement released on SENS on Tuesday, 28 April 2009 in which they were advised of the extension of the closing date of:

*the offer by AfroCentric's subsidiary ("the purchaser") to all of the shareholders of Lethimvula, other than the members of the AfroCentric group, ("offeree shareholders") to acquire all of their Lethimvula shares ("the offer"); and

*the offers by the purchaser to Dewald Dempers, in respect of the options he holds to subscribe for Lethimvula shares and Newshelf 755 (Pty) Ltd (African Vanguard Consortium), in respect of the options it holds to subscribe for Lethimvula shares.

*Prior to the offer, members of the AfroCentric group held 365 865 029 shares in Lethimvula representing 63.2% of the entire issued share capital of Lethimvula.



As at 12:00 on Friday, 29 May 2009, the closing date of the offer, the purchaser has received acceptances from offeree shareholders holding 117 817 466 shares in Lethimvula representing 20.4% of the entire issued share capital of Lethimvula. In addition, at this date the purchaser has received an acceptance from Newshelf 755 (Pty) Ltd (African Vanguard Consortium) of the offer made to it in respect of the options it holds to subscribe for Lethimvula shares.



Following the acquisition of the Lethimvula shares in respect of which acceptances have been received by the offeree shareholders, the AfroCentric group will hold 483 682 495 shares in Lethimvula representing 83.6% of the entire issued share capital of Lethimvula.
28 Apr 2009 13:16:58
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the announcement released on SENS on Thursday, 19 March 2009. As at 12:00 on Tuesday, 28 April 2009, AfroCentric has received acceptances from offeree shareholders holding 86 961 530 shares in Lethimvula representing 15.03% of the entire issued share capital of Lethimvula. In addition, at this date the AfroCentric group has received an acceptance from Newshelf 755 (Pty) Ltd (African Vanguard Consortium), in respect of the options it holds to subscribe for Lethimvula shares. Following the acquisition of the Lethimvula shares in respect of which acceptances have been received by the offeree shareholders, the AfroCentric group holds 452 826 559 shares in Lethimvula representing 78.23% of the entire issued share capital of Lethimvula.



Offeree shareholders and option holders are hereby notified that the scheduled closing date of the offer and offers to option holders of Thursday, 30 April 2009 per the Announcement has been extended to Friday, 29 May 2009. The revised salient dates and times are indicated in the table below:

*Closing date of the offer to the offeree shareholders (12:00) -- Friday, 29 May 2009

*Results of the offer to be released on SENS -- Monday, 1 June 2009
30 Mar 2009 10:24:52
(C)
AfroCentric's profits after tax for the period under review amounted to R8 772 000 (R3 268 000). This significant increase arises as a result of the escalated net yield on the conversion of interest bearing securities into the aforesaid preference shares. In addition, this is the first time that AfroCentric reflects equity accounted earnings of Jasco for a six month period. While operating divisions of Jasco performed relatively well under difficult market conditions, the attributable earnings of MTec in Jasco were disappointing during this period. The group reported headline earnings per share of 6.09c (3.48c).



Dividends

No dividends were declared or paid during the year under review.



Prospects

The board of directors and board investment committee of AfroCentric are satisfied with the progress of AfroCentric to date and will continue to follow the cautious approach and rigid principles of its investment policy. The board of Lethimvula recently announced the acquisition by Medscheme of Old Mutual Healthcare, and the appointment by the Oxygen Medical Scheme of Medscheme as its new administrator. The board of AfroCentric was party to these negotiations and fully supported the acquisition, including the future relationship agreement with Old Mutual.
27 Mar 2009 11:45:49
(Official Notice)
The board of Directors of AfroCentric advises that its basic headline earnings and earnings per share and fully diluted headline earnings and earnings per share for the six months ended 31 December 2008 is expected to show an increase of between 70% and 80% compared to the comparable period of 31 December 2007. The information contained in this trading statement has not been reviewed or reported on by the company's external auditors. AfroCentric will release its interim results for the six month period ended 31 December 2008 on 31 March 2009.
19 Mar 2009 13:35:25
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the announcement released on SENS on Friday, 27 February 2009 and to the circular posted to Lethimvula shareholders on that date in which they were advised of:

*the offer by AfroCentric to all of the shareholders of Lethimvula, other than the AfroCentric group, ("offeree shareholders") to acquire all of their Lethimvula shares ("the offer"); and

*the offers to Dewald Dempers, in respect of the options he holds to subscribe for Lethimvula shares and Newshelf 755 (Pty) Ltd (African Vanguard Consortium), in respect of the options it holds to subscribe for Lethimvula shares (collectively, the "option holders").



At 12:00 on Wednesday, 18 March 2009, AfroCentric has received acceptances from offeree shareholders holding 21 953 573 shares in Lethimvula and has not received any acceptances from the option holders. Following the acquisition of the Lethimvula shares in respect of which acceptances have been received by the offeree shareholders, AfroCentric holds 387 818 602 shares in Lethimvula representing 67% of the entire issued share capital of Lethimvula.



Given certain unforeseen delays in the postal distribution of the circular, offeree shareholders and option holders are hereby notified that the scheduled closing date of the offer and offers to option holders of Friday, 20 March 2009 has been extended to Thursday, 30 April 2009. The revised salient dates and times are indicated in the table below:

*Closing date of the offer to the offeree shareholders (12:00) -- Thursday, 30 April 2009

*Results of the offer to be released on SENS -- Monday, 4 May 2009
27 Feb 2009 07:11:41
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the joint AfroCentric and Lethimvula announcements released on SENS of the JSE Ltd on 30 January 2009 in which they were advised that AfroCentric had acquired 63.2% of the entire issued share capital of Lethimvula and that pursuant to the Securities Regulation Code on Take-Overs and Mergers. AfroCentric is obliged to make a mandatory offer to all shareholders of Lethimvula other than AfroCentric and its subsidiary and associate companies, to acquire all of their Lethimvula shares.



This announcement sets out the pro forma financial effects and salient dates of the offer to the offeree Shareholders. A circular setting out the terms and conditions of the offer is to be posted to the offeree shareholders.



Salient dates

Suspension of OTC trading of Lethimvula shares - Friday, 13 February 2009

Opening date of the offer to the offeree shareholders - Monday, 2 March 2009

Closing date of the offer to the offeree shareholders - Friday, 20 March 2009
30 Jan 2009 17:24:42
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the joint AfroCentric and Lethimvula announcements released on SENS on 23 September 2008 and the subsequent announcements thereto, in which they were advised that AfroCentric had entered into a share purchase agreement to acquire 365 865 029 ordinary shares in the issued share capital of Lethimvula representing 63.2% of the entire issued share capital of Lethimvula from certain Lethimvula shareholders.



Shareholders of both AfroCentric and Lethimvula are advised that all of the conditions precedent to the acquisition have now been fulfilled. A further announcement setting out the salient dates and times and the pro forma financial effects of the offer on the Lethimvula shareholders will be made within 30 days of this announcement. A circular, providing further information on the offer is expected to be posted to the Lethimvula shareholders in due course.
26 Jan 2009 11:42:32
(Official Notice)
At the annual general meeting of AfroCentric held on 26 January 2009, all the resolutions proposed thereat were passed by the requisite majority of shareholders.
09 Jan 2009 14:45:40
(Official Notice)
AfroCentric shareholders are advised that at the respective general meetings of the AfroCentric shareholders all the resolutions proposed thereat to approve inter alia the acquisition and resulting obligatory offer were passed by the requisite majority of AfroCentric shareholders respectively present in person or by proxy. In this regard, 99.9% of the AfroCentric ordinary shareholders present and entitled to vote at the meeting and 100% of the AfroCentric preference shareholders present and entitled to vote at the meeting voted in favour of the proposed resolutions.

The special resolution will be lodged with the registrar of companies for registration.



Conditions Precedent

Shareholders of both AfroCentric and Lethimvula are advised of the following remaining conditions precedent to the acquisition:

*Nedbank Ltd agreeing to the delivery of the sale shares held by the sellers to AfroCentric.The approval has been obtained from Nedbank and is subject to the acquisition becoming unconditional.

*AfroCentric raising such funding which will enable it to discharge the upfront cash portion of the purchase price of the acquisition and fulfil its obligations in respect of any offers which it has to make to the remaining shareholders of Lethimvula by no later than 31 January 2009.AfroCentric has now concluded and signed the funding agreements, subject to the fulfilment of conditions as are standard in agreements of this nature.

It is anticipated that the above conditions precedent will be fulfilled by 31 January 2009, at such time an announcement will be released on SENS to state that the acquisition is unconditional.



Obligatory offer

Should the acquisition of the sale shares become unconditional, the acquisition will be an "affected transaction" as defined in the securities regulation code on take-overs and mergers and accordingly AfroCentric shall be obliged to make an offer to the shareholders of Lethimvula in accordance with the provisions of the SRP code. AfroCentric accordingly has undertaken to make the obligatory offer to the offeree shareholders on the same terms and conditions as those on which the sale shares are purchased from the sellers.
23 Dec 2008 10:40:01
(Official Notice)
Shareholders are advised that the annual report of the company will be posted to shareholders on or about 30 December 2008 and that it contains no material modifications to the audited results announced on 30 September 2008. Notice was given the annual general meeting of the company will be held at the Auditorium, Ground Floor, 76 Maude Street, corner West Street, Sandton, on Monday, 26 January 2009 at 10:00 to transact business as stated in the notice of AGM forming part of the annual report.
18 Dec 2008 11:59:05
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the joint AfroCentric and Lethimvula announcement released on the securities exchange news service of the JSE ltd on 23 September 2008, as well as the subsequent announcements released on SENS on 15 October, 31 October and 3 December 2008 and are advised that the definitions as set out in the preceding announcements are equally applicable to this announcement.

A circular incorporating revised listings particulars is to be posted to the AfroCentric ordinary shareholders and the AfroCentric preference shareholders. This Circular includes a notice of general meeting of the AfroCentric ordinary shareholders and a notice of general meeting of the AfroCentric preference shareholders, which notices contain all of the ordinary and special resolutions which the AfroCentric ordinary shareholders and AfroCentric preference shareholders respectively will be required to consider and approve with or without modification in order to approve the acquisition and resulting obligatory offer.
03 Dec 2008 12:58:19
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the joint AfroCentric and Lethimvula announcement released on SENS on 23 September 2008, as well as the subsequent announcements released on SENS on 15 and 31 October 2008, and are advised that the date for fulfilment of the following conditions precedent being 30 November 2008, has been extended by AfroCentric to 31 January 2009:

*approval of the acquisition by the AfroCentric shareholders;

*obtaining such regulatory approvals as are required to implement the acquisition; and

*raising such funding to enable AfroCentric to discharge the upfront cash portion payable in terms of the acquisition and the obligatory offer. In this regard a term sheet has been signed subject to, inter alia, the signature of final legal agreements
15 Oct 2008 17:17:12
(Official Notice)
Shareholders of both AfroCentric and Lethimvula are referred to the joint AfroCentric and Lethimvula announcement released on SENS of the JSE Ltd on 23 September 2008 in which they were advised that AfroCentric had entered into a share purchase agreement to acquire 63.2% of the entire issued share capital of Lethimvula (the "acquisition") from certain Lethimvula shareholders and are advised that the date for fulfilment of the conditions precedent relating to the approval of the Acquisition by the board of directors of AfroCentric and the conclusion of a due diligence of Lethimvula to the satisfaction of AfroCentric, being 15 October 2008, has been extended by AfroCentric to 31 October 2008. Shareholders of both AfroCentric and Lethimvula are advised to continue exercising caution in trading their shares until such time as a further announcement containing, inter alia, the pro forma financial effects of the acquisition is made.
30 Sep 2008 09:41:28
(C)
AfroCentric's group profits after tax amounted to R10.81 million (R4.67 million), an increase of 131% for the year under review. This increase arises substantially as a result of the escalating yields on the company's cash resources for eleven months of the year, equity accounted earnings of Jasco for the month of June 2008. Headline earnings per share increased by 97.85% to 11.04c (5.58c).



Dividends

No dividends were declared or paid during the year under review.



Prospects

The board of directors and Board Investment Committee of AfroCentric are satisfied with the general progress of AfroCentric to date. Given that there is great economic uncertainty in both local and international investment markets, the cautious and disciplined investment policy adopted by the Board Investment Committee has served the best interests of AfroCentric shareholders. The Board Investment Committee will continue to follow the rigid principles of its investment policy, even though it is becoming increasingly evident that investment opportunities now present greater value than options proffered in the more feverish years of 2006 and 2007. There is a measure of confidence that current economic conditions present a more fertile landscape of opportunity for AfroCentric's long term vision and values, a typical example being the joint announcement between AfroCentric and Lethimvula released on SENS on 23 September 2008. In addition to the expected advantages arising through the Lethimvula acquisition and the Jasco investment, progress was made during the year completing the targets for consolidation of certain mineral rights, in conjunction with Rio Tinto Plc. Notwithstanding the long term nature of these mining related activities, including the normal feasibility risks in such projects, the mineral exploration and prospecting presently being undertaken with Rio Tinto Plc is encouraging.
29 Sep 2008 14:52:35
(Official Notice)
Shareholders are advised that the company's earnings and headline earnings per share for the financial year ended 30 June 2008 are expected to be between 80% and 100% higher than the earnings and headline earnings per share for the previous corresponding period, 30 June 2007. The results for the financial year ended 30 June 2008 are expected to be published on or about 29 September 2008.
23 Sep 2008 14:31:25
(Official Notice)
The boards of directors of AfroCentric and Lethimvula hereby announce that AfroCentric has entered into a share purchase agreement, dated 22 September 2008 to acquire 365 865 029 ordinary shares in the issued ordinary share capital of Lethimvula, representing 63.2% of the entire issued share capital of Lethimvula, from certain Lethimvula shareholders. Lethimvula is an investment holding company with its principal assets being a 100% beneficial interest in Medscheme Ltd and Rowan Angel (Pty) Ltd.



Given the relative values of Lethimvula and AfroCentric, the structure of the acquisition and the mandatory offer will result in a reverse take-over of the company. The JSE will only permit the company to retain its listing, following the reverse take-over, should the JSE be satisfied that the company will continue to qualify for a JSE listing in terms of the Listings Requirements of the JSE. The directors of the company are confident that the company will continue to qualify for listing after the implementation of the acquisition and mandatory offer.



Given that the pro forma financial effects of the acquisition will be communicated to AfroCentric and Lethimvula shareholders in due course, shareholders of both AfroCentric and Lethimvula are advised to continue exercising caution in trading their shares until such time as a further announcement is made. If the acquisition is implemented, the mandatory offer will replace the composite offer contemplated in the cautionary announcement published by Lethimvula on 13 March 2008.
26 May 2008 17:14:11
(Official Notice)
Shareholders are advised that at the general meeting all the resolutions proposed thereat to approve the transactions related to the Jasco acquisition were passed by the requisite majority of shareholders present in person or by proxy.



Remaining conditions precedent

Save for the approval of the Securities Regulation Panel ("SRP") to grant dispensation, following the waiver granted by Jasco shareholders at the Jasco general meeting held today, to waive the requirement for CIH and AfroCentric to make a mandatory offer to all Jasco shareholders, all conditions precedent for the acquisition have been met. It is anticipated that this dispensation will be obtained from the SRP by the latest close of business on Tuesday, 27 May 2008. In terms of the subscription, all conditions precedent have been met save for the registration of the special resolutions passed by Jasco shareholders today with the Registrar of Companies. Shareholders will be informed when all the remaining conditions precedent have been fulfilled and the transactions have therefore become effective
25 Apr 2008 12:24:53
(Official Notice)
Further to the announcement dated 3 April 2008, shareholders were advised that AfroCentric has entered into an agreement, dated 31 March 2008, with Community Investment Holdings (Pty) Ltd (CIH), The Inkonkoni Trust, Malesela Holdings No. 1 (Pty) Ltd (Malesela) and Jasco to acquire 34.9% of the ordinary shares in Jasco subsequent to the redemption of convertible preference shares held in Jasco by CIH and the subscription by CIH of ordinary shares in Jasco. The Acquisition will be effective from the first day of the month following the month in which the closing date falls, which is 9 business days after all conditions precedent, have been fulfilled, and expected to be before 31 May 2008. Further to the Acquisition, AfroCentric has entered into an agreement, dated 31 March 2008, with Jasco and Iningi, a wholly owned subsidiary of Jasco, to subscribe for 40 000 cumulative redeemable preference shares in the capital of Iningi for an aggregate subscription price of R100 million, being an issue price of R2 500 per Iningi preference share. The subscription will be implemented before 31 May 2008.



Shareholders are referred to the transaction announcement and renewal of cautionary dated 3 April 2008 and in light of the announcement of the pro forma financial effects, are advised that it is no longer required to exercise caution in dealing in AfroCentric shares.
03 Apr 2008 11:42:28
(Official Notice)
Holders of ordinary shares and preference shares in AfroCentric are advised that AfroCentric has entered into an agreement, dated 31 March 2008, with Community Investment Holdings (Pty) Ltd (CIH), The Inkonkoni Trust, Malesela Holdings No. 1 (Pty) Ltd and Jasco to acquire 34.9% of the ordinary shares in Jasco subsequent to the redemption of convertible preference shares held in Jasco by CIH. The Acquisition will be effective from the first day of the month following the month in which the closing date falls, which is 9 (nine) business days after all conditions precedent have been fulfilled, and expected to be before 31 May 2008.



The pro forma financial effects of the Transactions, setting out the impact of the Transactions on AfroCentric`s earnings and net asset value, prepared in terms of the JSE Listings Requirements, will be provided in a further announcement. Shareholders are referred to the cautionary announcement dated 27 March 2008 and accordingly, are advised to continue exercising caution when dealing in AfroCentric`s securities until the further announcement has been made.
27 Mar 2008 14:43:22
(C)
During the period under review, the company continued to facilitate the assembly and consolidation of certain prospecting, exploration and mining rights in the provinces of Limpopo and the North West. Subject to the successful outcome of exploration and prospecting presently in progress by the group's associates, Rio Tinto Mining Plc (Rio Tinto), these rights are in due course expected to form part of joint venture projects to be concluded between AfroCentric and Rio Tinto. The company awaits the outcome of other prospecting, exploration and mining rights applications submitted through certain of the provincial Departments of Minerals and Energy. In addition to the above mining matters, during the period under review, numerous investment opportunities were presented and considered by the board investment committee. Afrocentric reported basic earnings per share of 3.48c (2.58c) for the six months ended 31 December 07.



Prospects

Exploration and prospecting by its very nature is a long term process. Nevertheless, the general course and conduct of the strategic co-operation agreement with Rio Tinto is working well and the board remains optimistic about the matters in progress and the potential results which could evolve through this relationship. The board remains committed to propositions that are commercially sound and satisfy the strict investment criteria specified by the board investment committee. Suitable investments will be concluded at the appropriate time on terms which are considered to be in the best interest of shareholders. One such investment proposal has reached an advanced stage of negotiation.
30 Jun 2006 17:53:08
(Official Notice)
Further to the announcement on SENS on 23 June 2006 relating to renounceable rights offers of:

* 84 600 000 AfroCentric ordinary shares at a subscription price of 100c each, in the ratio of 900 new ordinary shares for every 100 ordinary shares held in AfroCentric; and

* 16 638 000 AfroCentric redeemable preference shares at a subscription price of 91c each, in the ratio of 177 new redeemable preference shares for every 100 ordinary shares held in AfroCentric; and

*a mandatory offer at 100c per ordinary share to minority AfroCentric shareholders following a change of control pursuant to the rights offers;

formal approval has now been received from the Committee of the JSE and the letters of allocation and accompanying documents have been lodged with the Registrar of Companies for registration.



Salient dates

*Last day to trade in AfroCentric shares in order to qualify to participate in the rights offers (cum entitlement) on Friday, 14 July

*AfroCentric shares commence trading ex rights on the JSE at 09:00 on Monday, 17 July

*Rights offers and mandatory offer open at 09:00 on Monday, 24 July

*Last day to trade in ordinary shares to be eligible to participate in the Thursday, 3 August mandatory offer to minority shareholders

*Listing and trading of rights offer shares on the JSE commences at 09:00 on Friday, 4 August

*Results of rights offers, mandatory offer, and abridged revised listing particulars published on SENS on Monday, 14 August
23 Jun 2006 12:12:02
(Official Notice)
26 May 2006 10:32:27
(Official Notice)
Shareholders are referred to the cautionary announcements dated 31 March 2006 and 12 April 2006 and are advised that the company is still considering the rights offer referred to therein. Shareholders should continue to exercise caution when dealing in the company's securities until a further announcement is made.
26 May 2006 10:26:45
(Official Notice)
Mr Brian Joffe joined the board of AfroCentric with immediate effect (26 May 06). Founder and Chief Executive of The Bidvest Group, Brian will be joining Meyer Kahn and Michael (Motty) Sacks as investors in AfroCentric pursuant to the forthcoming rights offer to be announced shortly.
09-Feb-2018
(X)
AfroCentric is a black-empowered investment holding company with an investment portfolio focused on providing services to the healthcare sector. Through its operating subsidiaries, AfroCentric provides health administration and health risk management solutions.
12 Apr 2006 15:59:10
(Official Notice)
Further to the announcement released on SENS on 31 March 2006 relating to the passing of the special and ordinary resolutions necessary to reconstitute the company, alter and increase the share capital, and change the name to AfroCentric Investment Corporation Ltd, the special resolutions have not yet been registered at the Companies and Intellectual Properties Registration Office. Accordingly, the salient dates have been revised.



*Last day to trade in shares under the name WB Holdings Ltd -- Friday, 12 May

*Ordinary shares commence trading under the name AfroCentric Investment Corporation Limited Short name: AFRO-C Code: ACT ISIN: ZAE000078416 -- Monday, 15 May

*Record date for the name change Friday, 19 May

Shareholders are referred to the cautionary announcement dated 31 March 2006 and are advised that the restructuring of the company referred to therein is continuing. The next phase of such restructuring will be the rights offer referred to in previous announcements. Shareholders should continue to exercise caution when dealing in the companys securities until a further announcement is made.

31 Mar 2006 16:04:51
(Official Notice)
At the general meeting of shareholders of the company held on 31 March 2006, all the special and ordinary resolutions necessary to reconstitute the company, alter and increase the share capital, and change the name to AfroCentric Investment Corporation Ltd were passed with the requisite majorities. The special resolutions are being lodged for registration.



*Last day to trade in shares under the name WB Holdings Ltd Thursday, 20 April

*Ordinary shares commence trading under the name AfroCentric Investment Corporation Limited Short name: AFRO-C Code: ACT ISIN: ZAE000078416 -- Friday, 21 April

* Record date for the name change Friday, 28 April

Renewal of cautionary announcement

Shareholders are referred to the cautionary announcement dated 1 February 2006 and are advised that the restructuring of the company is continuing. The next phase of such restructuring will be the rights offer referred to in previous announcements. Shareholders should continue to exercise caution when dealing in the company's securities until a further announcement is made.
10 Mar 2006 17:44:59
(Official Notice)
Shareholders are advised that the reorganisation and restructuring referred to in the December 2005 interim results published on Sens on 10 March 2006, and in the cautionary announcements dated 20 December 2005 and 1 February 2006 continue. Details regarding the reorganisation are contained in a circular to shareholders dated 6 March 2006 convening a shareholders' meeting to be held on 31 March 2006. Details of the recapitalisation will be announced in the near future and shareholders should continue to exercise caution when dealing in the company's securities until such time.
10 Mar 2006 17:41:29
(C)
The operating loss for the period includes the net loss on disposal of the company's subsidiary of R4 522 000. The unaudited interim results of operations for the six months ended 31 December 2005 reflect and give effect to the corporate transactions described below and are not meaningfully comparable with the unaudited results for the same period in the prior year or to the audited results for the fiscal year ended 30 June 2005.



In terms of a circular to shareholders dated 10 November 2005, a shareholders' meeting was convened on 28 November 2005 at which shareholders approved the sale of its entire business undertaking to SGM Investments (Pty) Ltd for R19 million and declared a special dividend to shareholders of R1.82 per share. This left the company as a "cash shell" as defined in the JSE Listings Requirements, holding approximately R1 million in cash after provisions, as its sole asset.



It was announced on SENS on 28 October 2005 and in the press on 29 October 2005 that Messrs. J M Kahn and M I Sacks (or their nominees) had agreed to purchase 80% of the issued shares in WB Holdings. The purchase was conditional upon several items including JSE approval to maintain the listing of the company and approval of the SRP to waive the mandatory offer to minority shareholders. The company sought and received approval from the JSE to maintain the listing after the purchase. The SRP waived the mandatory offer otherwise required, subject to the approval of the company's shareholders, which approval was sought and received at the shareholders' meeting on 28 November 2005. The purchase was concluded and announced on SENS on 20 December 2005. The existing board of directors of the company was replaced with effect from 20 December 2005 by N B Bam, N Canca, M Gantsho, J M Kahn, M I Sacks and D I Swartz.



Concurrently with that announcement the company issued a cautionary announcement indicating that initiatives were being finalised to recapitalise the company, to introduce BEE associates and other stakeholders and to change the company's name. The company also indicated that it intended to approach the JSE to change the sector on which the company is listed.
09 Mar 2006 17:02:35
(Official Notice)
The directors propose to reconstitute the company as a black empowered diversified investment holding company. In furtherance of this objective the following steps will be taken, in addition to the appointment of a new board, which has already taken place:

*the authorised share capital of the company will be altered and increased to consist of additional ordinary shares and listed redeemable participating preference shares of one cent each.

*the company's name will be changed to AfroCentric Investment Corporation Ltd.

*the company's Memorandum and Articles of Association will be amended.

*new share incentive scheme will be adopted.

Shareholders representing 80% of the ordinary shares entitled to vote at the general meeting have undertaken in writing to vote their shares in favour of the special and ordinary resolutions. Following the implementation of the above, it is intended that the company will make a rights offer in compliance with JSE requirements to its ordinary shareholders of new ordinary shares and new redeemable preference shares in order to raise additional equity capital.



Salient dates :

*General meeting of WB Holdings shareholders at 10h00 on Friday, 31 March 06

*Announcement of results of general meeting on SENS on Friday, 31 March 06

*Last day to trade in shares under the name WB Holdings Ltd on Thursday, 20 April 06

*Ordinary shares commence trading under the name AfroCentric Investment Corporation Ltd (Short name : AFRO-C - Code : ACT) with ISIN : ZAE000078416 on Friday, 21 April 06



A general meeting of shareholders will be held on Friday, 31 March 2006 for the purpose of considering and, if deemed fit, passing, with or without modification, the special and ordinary resolutions required to approve and implement the reconstitution. A circular setting out the details of the reconstitution and containing a notice of general meeting was posted to shareholders on 6 March 2006. A further announcement advising shareholders of the results of the general meeting will be published after the general meeting on or about Friday, 31 March 2006.


Send e-mail to for any enquiries or see Contact Details for phone numbers
Home   •   Terms & conditions   •   PAIA   •   Privacy Policy   •   Security Notice   •   Contact Details
Market Statistics are calculated by Sharenet and are therefore not the official JSE Market Statistics. The calculation/derivation may include underlying JSE data.
© 2018 SHARENET (PTY) Ltd, Cape Town, South Africa
Best in 800x600 with IE6 or Mozilla Firefox